Fig. 4From: Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictorSubject 2006. NG12-1 treatment area (ink marks) showing reduced radiodermatis on Day 35. The interim analysis score was +++Back to article page